Study S001366

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02042664
Study type: INTERVENTIONAL
Allocation: NON_RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 44
Start: 2011-01
Primary completion: 2015-01
Lead sponsor: Assistance Publique Hopitaux De Marseille
Conditions: Obesity; Diabetes
Interventions: DRUG:BYETTA treatment; DRUG:Metformine
Results posted: FALSE
Secondary identifiers: OTHER:2010-14

Registered primary outcomes

intracardiac triglyceride [3 years]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0023213	Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy. Dutour A, Diabetes, obesity & metabolism	2016	Randomized trial	PMID 27106272 DOI	registry reference RESULT:27106272